Logo image of AVTX.AS

AVANTIUM (AVTX.AS) Stock Fundamental Analysis

AMS:AVTX - Euronext Amsterdam - NL0012047823 - Common Stock - Currency: EUR

1.746  +0.04 (+2.22%)

Fundamental Rating

2

AVTX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 30 industry peers in the Professional Services industry. AVTX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AVTX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AVTX has reported negative net income.
In the past year AVTX has reported a negative cash flow from operations.
AVTX had negative earnings in each of the past 5 years.
In the past 5 years AVTX always reported negative operating cash flow.
AVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFAVTX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.32%, AVTX is doing worse than 88.89% of the companies in the same industry.
The Return On Equity of AVTX (-25.57%) is worse than 88.89% of its industry peers.
Industry RankSector Rank
ROA -9.32%
ROE -25.57%
ROIC N/A
ROA(3y)-20.79%
ROA(5y)-23.88%
ROE(3y)-50.29%
ROE(5y)-46.95%
ROIC(3y)N/A
ROIC(5y)N/A
AVTX.AS Yearly ROA, ROE, ROICAVTX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

AVTX has a better Gross Margin (83.18%) than 74.07% of its industry peers.
AVTX's Gross Margin has been stable in the last couple of years.
AVTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y0.65%
AVTX.AS Yearly Profit, Operating, Gross MarginsAVTX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

AVTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AVTX has been increased compared to 1 year ago.
The number of shares outstanding for AVTX has been increased compared to 5 years ago.
Compared to 1 year ago, AVTX has a worse debt to assets ratio.
AVTX.AS Yearly Shares OutstandingAVTX.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AVTX.AS Yearly Total Debt VS Total AssetsAVTX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -1.05, we must say that AVTX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AVTX (-1.05) is worse than 96.30% of its industry peers.
AVTX has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.15, AVTX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Altman-Z -1.05
ROIC/WACCN/A
WACC6.74%
AVTX.AS Yearly LT Debt VS Equity VS FCFAVTX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M 150M

2.3 Liquidity

A Current Ratio of 1.37 indicates that AVTX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.37, AVTX is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
AVTX has a Quick Ratio of 1.33. This is a normal value and indicates that AVTX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, AVTX is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.33
AVTX.AS Yearly Current Assets VS Current LiabilitesAVTX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

AVTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.51%, which is quite impressive.
Looking at the last year, AVTX shows a small growth in Revenue. The Revenue has grown by 6.42% in the last year.
Measured over the past years, AVTX shows a quite strong growth in Revenue. The Revenue has been growing by 11.79% on average per year.
EPS 1Y (TTM)25.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.42%
Revenue 1Y (TTM)6.42%
Revenue growth 3Y25.94%
Revenue growth 5Y11.79%
Sales Q2Q%23.37%

3.2 Future

The Earnings Per Share is expected to grow by 14.62% on average over the next years. This is quite good.
AVTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.71% yearly.
EPS Next Y27.89%
EPS Next 2Y17.67%
EPS Next 3Y19.39%
EPS Next 5Y14.62%
Revenue Next Year21.78%
Revenue Next 2Y52.4%
Revenue Next 3Y59.25%
Revenue Next 5Y34.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVTX.AS Yearly Revenue VS EstimatesAVTX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AVTX.AS Yearly EPS VS EstimatesAVTX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AVTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVTX.AS Price Earnings VS Forward Price EarningsAVTX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVTX.AS Per share dataAVTX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

AVTX's earnings are expected to grow with 19.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.67%
EPS Next 3Y19.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVTX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTIUM

AMS:AVTX (2/5/2025, 12:45:07 PM)

1.746

+0.04 (+2.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-21 2024-08-21
Earnings (Next)N/A N/A
Inst Owners16.78%
Inst Owner ChangeN/A
Ins Owners5.44%
Ins Owner ChangeN/A
Market Cap150.38M
Analysts76.67
Price Target4.47 (156.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.98%
PT rev (3m)0.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)19.88%
EPS NY rev (3m)27.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.1%
Revenue NY rev (3m)-4.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.03
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.25
BVpS1.15
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.32%
ROE -25.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.18%
FCFM N/A
ROA(3y)-20.79%
ROA(5y)-23.88%
ROE(3y)-50.29%
ROE(5y)-46.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y0.65%
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1329.44%
Cap/Sales 377.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.33
Altman-Z -1.05
F-Score2
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)560.24%
Cap/Depr(5y)374%
Cap/Sales(3y)227.39%
Cap/Sales(5y)155.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.42%
EPS Next Y27.89%
EPS Next 2Y17.67%
EPS Next 3Y19.39%
EPS Next 5Y14.62%
Revenue 1Y (TTM)6.42%
Revenue growth 3Y25.94%
Revenue growth 5Y11.79%
Sales Q2Q%23.37%
Revenue Next Year21.78%
Revenue Next 2Y52.4%
Revenue Next 3Y59.25%
Revenue Next 5Y34.71%
EBIT growth 1Y-47.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.18%
EBIT Next 3Y23.3%
EBIT Next 5Y30.79%
FCF growth 1Y-267.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.45%
OCF growth 3YN/A
OCF growth 5YN/A